With Congress locked in a critical battle over fiscal talks, the looming threat of a government shutdown on October 1 may spell potential delays in Food and Drug Administration approvals of new drugs, FierceBiotech reports.
http://www.poz.com/rssredir/articles/government_shutdown_761_24571.shtml
http://www.poz.com/rssredir/articles/government_shutdown_761_24571.shtml
No comments:
Post a Comment